Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Fludarabine phosphate
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Fludara 10mg tablets
0801030W0BBAAAA
|
Fludara | Fludarabine phosphate | Malignant Disease and Immunosuppression | No data available |
|
Fludara 50mg powder for solution for injection vials
0801030W0BBABAB
|
Fludara | Fludarabine phosphate | Malignant Disease and Immunosuppression | No data available |
|
Fludarabine phosphate 10mg tablets
0801030W0AAAAAA
|
Fludarabine phosphate | Fludarabine phosphate | Malignant Disease and Immunosuppression | No data available |
|
Fludarabine phosphate 50mg inj vials
0801030W0AAABAB
|
Fludarabine phosphate | Fludarabine phosphate | Malignant Disease and Immunosuppression | No data available |
|
Fludarabine phosphate 50mg/2ml solution for injection vials
0801030W0AAACAC
|
Fludarabine phosphate | Fludarabine phosphate | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.